CIRM Directors to Address Business IP and Lab Grants
Directors of the California stem cell agency meet next Wednesday with a $220 million matter foremost in their minds, but other issues, such as intellectual property rules for grants to businesses, also are up for action.
Criteria and procedures for the $220 million lab grant RFA – the largest single grant effort by CIRM – are likely to dominate the disc…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.